市場調查報告書
商品編碼
1249920
全球睡眠呼吸暫停設備市場 - 按產品、最終用途、2023-2032 年預測Sleep Apnea Devices Market - By Product, By End-use & Global Forecast, 2023 - 2032 |
由於睡眠障礙和相關合併症的增加,預計到 2032 年睡眠呼吸暫停設備將保持積極的發展軌跡。
據可靠報導,大約有 2200 萬美國人患有睡眠呼吸暫停症。 睡眠呼吸暫停在老年人口和相關健康狀況中的患病率不斷增加,這增加了對睡眠障礙診斷和治療設備的需求。
治療阻塞性睡眠呼吸暫停的最新方法是 Inspire 系統。 通過激活舌頭和呼吸道的肌肉,它不僅試圖治療症狀,而且試圖從根本上治療睡眠呼吸暫停綜合徵。 這些圍繞睡眠呼吸暫停的發展有望在未來幾年為市場擴張提供有利可圖的機會。
總體而言,睡眠呼吸暫停設備行業根據產品、最終用途和區域進行細分。
基於產品,診斷行業預計將在未來幾年繼續快速增長。 在睡眠呼吸暫停治療設備領域,不斷的技術創新正在擴大其在全球範圍內的使用範圍。 這些設備具有非侵入式監測睡眠週期和提供隨時間變化的睡眠模式圖形摘要的多重優勢。
就最終用途而言,到 2032 年底,睡眠實驗室和醫院部分將保持強勁勢頭,因為患者越來越喜歡睡眠實驗室和醫院,因為他們的高質量睡眠障礙治療和可負擔性預計會增長。 此外,睡眠實驗室和醫院能夠做出準確的診斷並提供準確有效的治療,從而以可承受的價格提供最佳的治療效果。
按地區劃分,預計從 2023 年到 2032 年,亞太地區的睡眠呼吸暫停治療行業將出現顯著增長。 由於睡眠呼吸暫停綜合徵患病率上升,預計該地區的市場增長將主要受到對睡眠呼吸暫停綜合徵早期診斷需求不斷增長的推動。 一項關於阻塞性睡眠呼吸暫停低通氣綜合徵的研究發現,OSA 在印度次大陸的患病率在 4.4% 到 13.7% 之間。
越來越多的市場進入者、積極的政府舉措和發達的醫療保健基礎設施也將對該地區的前景產生積極影響。 預計亞太地區老齡化人口的快速增加將推動業務增長,並在未來幾年進一步加速市場擴張。
Sleep Apnea Devices industry will depict positive trajectory through 2032 owing to the increasing prevalence of sleep disorders and related co-morbidities. According to credible reports, around 22 million Americans have sleep apnea. The growing senior population prone to sleep apnea and related health conditions have bolstered the demand for sleep disorders diagnosis & treatment equipment.
The most recent method of treating obstructive sleep apnea is the Inspire system. Inspire attempts to treat the root of sleep apnea, not just the symptoms, by activating the tongue and airway muscles. Such developmental trends around sleep apnea are likely to offer lucrative opportunities to the market expansion in the coming years.
Overall, the sleep apnea devices industry is segmented in terms of product, end-use and region.
Based on the product, the diagnostics segment will grow rapidly through 2032 due to the increasing demand for sleep apnea devices for sleep disease diagnosis and rising awareness regarding the benefits of advanced diagnostic sleep apnea devices. Constant technological innovations in the field of sleep apnea devices is enhancing its use globally. These devices offer multiple advantages in monitoring sleep cycles using a non-invasive method and providing a graphical summary of sleep patterns over time.
By end-use, the sleep laboratories & hospitals segment will demonstrate sturdy growth by 2032 end, owing to the increasing preference of patients towards sleep laboratories & hospitals for quality sleep disorders treatment and affordability. In addition, sleep laboratories & hospitals offer an accurate diagnosis that empower precise & effective treatment, thus delivering optimal treatment outcomes along with affordability.
Regionally, the Asia Pacific sleep apnea devices industry is estimated to garner notable gains during 2023-2032. The regional market growth will come from the mounting demand for early diagnosis of sleep apnea, mainly due to the rising prevalence of sleep apnea. As per a study on Obstructive Sleep Apnea Hypopnea Syndrome, the OSA prevalence ranges from 4.4% to 13.7% in the Indian subcontinent.
Besides, the increasing number of key participants entering the market, along with favorable government initiatives and well-developed healthcare infrastructure, will favor the regional outlook. The surging geriatric population base in the Asia Pacific region is anticipated to push the business growth, further amplifying the market expansion in the coming years.